Triaprin

   
Google
 
Web NewDrugInformation.com

Triaprin


Drug - Triaprin
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetaminophen; Butalbital
Multiple ingredients are in alphabetical order.

Strength - 325MG;50MG
The potency of the active ingredient(s), Acetaminophen; Butalbital. May repeat for multiple part products.

Applicant - DUNHALL
The firm name holding legal responsibility for Triaprin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 089268
The FDA assigned number to Triaprin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Triaprin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 2, 1987
The date Triaprin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Triaprin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Triaprin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Dunhall Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Triaprin.

Triaprin